Luiz Noronha is a partner at DNA Capital, focused on venture capital investments.

Luiz is a board member at Beep Saúde, Nuria, Memed, Sanar, Carevoice, and Cíngulo. Previously, he was a board member at Feegow, Nexa Saúde, and Blüüm.

He has over ten years of experience investing in early-stage companies. Before joining DNA Capital, he invested in technology companies at DGF Investimentos, where he participated on the boards of Ingresse, Gesto Saúde, RD Station, Concil, ADTsys, Mosyle, and Intellibrand. Previously, he was part of the investment team of Ficus Investimentos, where he acted as a board member and CFO of a portfolio company.

Luiz holds a Bachelor of Science degree in Mechanical Engineering from Universidade de São Paulo.